Related Experiment Video
Updated: Feb 25, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
HCV co-infection is associated with metabolic abnormalities among HAART naive HIV-infected persons
M A Kuti1, J O Akinyemi2, B O Ogunbosi3
1Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Insights
Hepatitis C Virus (HCV) co-infection in HIV-infected individuals may lower cholesterol levels but fasting plasma glucose may not indicate insulin resistance. This study examined metabolic changes in co-infected patients.
Area of Science:
- Infectious Diseases
- Metabolic Disorders
- Hepatology
Background:
- Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) co-infection is prevalent in certain populations.
- Metabolic abnormalities are common in individuals with chronic viral infections.
- Understanding these metabolic changes is crucial for managing co-infected patients.
Purpose of the Study:
- To investigate metabolic abnormalities in treatment-naïve, HIV-infected individuals with Hepatitis C Virus (HCV) co-infection.
- To assess fasting plasma glucose (FPG) and lipid profiles in this co-infected population.
- To determine the relationship between HIV-HCV co-infection and metabolic parameters.
Main Methods:
- Retrospective review of clinical records of newly recruited HIV-infected patients.
- Analysis of baseline fasting plasma glucose and fasting lipid profiles.
- Comparison of metabolic parameters between HIV-HCV co-infected and HIV-only infected individuals.
Main Results:
- HCV co-infection was found in 6% of the 1,260 HIV-infected individuals studied.
- HIV-HCV co-infection was associated with lower median total cholesterol, LDL-cholesterol, and HDL-cholesterol.
- Median FPG was significantly higher in co-infected individuals, but no relationship was found with fasting glucose levels via regression analysis.
Conclusions:
- HIV-HCV co-infection appears linked to a decrease in plasma cholesterol levels.
- Fasting plasma glucose alone may be insufficient to identify insulin resistance in HIV-HCV co-infected individuals.
- Further research is needed to fully understand the metabolic implications of HIV-HCV co-infection.
Objectives:
To determine the metabolic abnormalities among Hepatitis C Virus (HCV) co infected HAART naïve HIV infected persons within the adult ARV clinic of the University College Hospital/University of Ibadan, Ibadan, Nigeria Methods: This was a retrospective study involving the review of clinical records of newly recruited HIV-infected persons in the adult antiretroviral (ARV) clinic over a 12 month period (January - December 2006). Baseline results for fasting plasma glucose (FPG) and fasting lipid profile were retrieved.
Results:
Out of the 1,260 HIV infected persons seen during the study period, HCV co-infection was found in 75 (6%) persons. The median values for total cholesterol, LDL-cholesterol and HDL-cholesterol were lower in the HCV co-infected persons. HIV-HCV co-infection was associated with a 0.31 mmol/L depression in Total Cholesterol (TC). The median FPG concentration was significantly higher in HIV-HCV co-infected than HIV only infected persons (5.33mmol/L vs. 5.00mmol/L, p = 0.047). However, regression analysis showed there was no relationship between the HIV-HCV co infected state and fasting glucose levels.
Conclusion:
HIV-HCV co-infection may be associated with a predictable decline in plasma cholesterol, but FPG may not be sufficient to demonstrate insulin resistance in these persons.
More Related Videos
10:12Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Retroviruses
Cardiomyopathy III: Hypertrophic Cardiomyopathy